Wood T L, Berelowitz M, Gelato M C, Roberts C T, LeRoith D, Millard W J, McKelvy J F
Department of Neurobiology and Behavior, SUNY, Stony Brook.
Neuroendocrinology. 1991 Mar;53(3):298-305. doi: 10.1159/000125732.
Hormonal feedback regulation of hypothalamic peptides putatively involved in growth hormone (GH) regulation has been studied by measurement of steady-state mRNA levels in male hypophysectomized rats with or without thyroid hormone, corticosterone, testosterone or GH replacement. Hypothalamic GH-releasing factor (GRF) mRNA levels increased progressively following hypophysectomy to 420% of sham levels after 15 days while hypothalamic insulin-like growth factor I (IGF-I) and insulin-like growth factor II (IGF-II) mRNA levels decreased to less than 40% of sham levels. Whole hypothalamic somatostatin mRNA levels were not significantly different from sham. One week of continuous GH infusion restored hypothalamic IGF-I mRNA to levels (95%) indistinguishable from those in sham-operated controls but had no effect on either IGF-II or GRF mRNA. Thyroid hormone, corticosterone and testosterone treatment without GH had no effect on the hypophysectomy-induced reduction of either IGF-I or IGF-II mRNA levels but reversed the elevation of GRF mRNA. We conclude that hypothalamic IGF-I may be involved in GH feedback regulation and thus may function as a hypothalamic modulator of GH. In contrast, IGF-II may be regulated by one of the pituitary trophic hormones but not by GH or the target hormones tested. Finally, hypothalamic GRF mRNA regulation appears to be complex and may include target hormone feedback.
通过测量雄性垂体切除大鼠在有或无甲状腺激素、皮质酮、睾酮或生长激素替代情况下的稳态mRNA水平,研究了可能参与生长激素(GH)调节的下丘脑肽的激素反馈调节。垂体切除后,下丘脑生长激素释放因子(GRF)mRNA水平逐渐升高,15天后达到假手术水平的420%,而下丘脑胰岛素样生长因子I(IGF-I)和胰岛素样生长因子II(IGF-II)mRNA水平降至假手术水平的40%以下。整个下丘脑生长抑素mRNA水平与假手术组无显著差异。连续一周输注生长激素可使下丘脑IGF-I mRNA水平恢复到与假手术对照组难以区分的水平(95%),但对IGF-II或GRF mRNA均无影响。在没有生长激素的情况下,甲状腺激素、皮质酮和睾酮治疗对垂体切除诱导的IGF-I或IGF-II mRNA水平降低没有影响,但可逆转GRF mRNA的升高。我们得出结论,下丘脑IGF-I可能参与生长激素的反馈调节,因此可能作为生长激素的下丘脑调节因子发挥作用。相比之下,IGF-II可能受一种垂体促激素调节,但不受生长激素或所测试的靶激素调节。最后,下丘脑GRF mRNA的调节似乎很复杂,可能包括靶激素反馈。